"Prevalence and Risk Factors of Adverse Drug Reactions Associated Multidrug Resistant Tuberculosis Treatments in Selected Treatment Centers in Addis Ababa Ethiopia"
written by Haregewoin Bezu, Daniel Seifu, Getnet Yimer, Tesfamariam Mebrhatu,
published by Journal of Tuberculosis Research, Vol.2 No.3, 2014
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort …
2019
[2] SEVERE ADVERSE EFFECTS ASSOCIATED WITH MULTIDRUG RESISTANT TUBERCULOSIS MEDICATIONS AMONG PATIENTS ATTENDING ALERT HOSPITAL, ETHIOPIA
Ethiopian medical journal, 2019
[3] Risk Factors of Gout in MDR-TB Patients in Eritrea: A Case-Control Study
2019
[4] Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara …
2019
[5] Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia
Thesis, 2019
[6] Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study
BMC Pharmacology & Toxicology, 2019
[7] Prevalence and Predictors of Adverse Drug Effects with Second Line Anti-TB drugs Under Programmatic Management of Drug Resistant Tuberculosis (PMDT) …
Indian Journal of Public Health Research & Development, 2018
[8] Adverse Drug Reactions (ADRs) and preventability, in elderly DR TB patients admitted at Tuberculosis Hospital in Mumbai, India
Journal of Medical Science And clinical Research, 2018
[9] Malnutrición como factor de riesgo para reacción adversa a fármacos antituberculosos en pacientes con tuberculosis en el Hospital Militar Central durante el período …
2018
[10] Second-line Anti-Tuberculosis Drugs and Risk of Alopecia: A Retrospective Cohort study
2018
[11] Severe Adverse Effects Associated with Multidrug Resistant Tuberculosis Medications among Patients attending ALERT Hospital, Ethiopia.
2018
[12] Prevalencia de reacciones adversas a fármacos antituberculosis en los establecimientos de la Dirección Regional de Salud Tacna, enero 2013–junio 2016
2017
[13] “Evaluation of Study Designs In Anti-Tubercular Regimen”–A
IOSR Journal of Pharmacy and Biological Sciences, 2017
[14] Survival and Its Determinant of Multidrug-Resistant Tuberculosis Patients with (HIV) Co-Infection: St. Peter Tuberculosis Specialized Hospital Addis Ababa, Ethiopia
2016
[15] SURVIVAL AND ITS DETERMINANT OF MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS WITH HIV CO-INFECTION: St. PETER TUBERCULOSIS …
Thesis, 2016
[16] JENIS–JENIS EFEK SAMPING PENGOBATAN OAT DAN ART PADA PASIEN DENGAN KOINFEKSI TB/HIV DI RSUP dr. KARIADI
2016
[17] Associated factors vs risk factors in cross-sectional studies
Patient preference and adherence, 2015
[18] Human Leukocyte Antigen-G (HLA-G) 14-bp deletion polymorphism is associated with decreased risk of pulmonary fibrosis in Indonesian Javanese patients with multidrug-resistant tuberculosis
Asian Biomed, 2015
[19] COMPARATIVE STUDY OF KANAMYCIN AND CAPREOMYCIN ON SERUM POTASSIUM LEVEL OF MULTIDRUG RESISTANCE TUBERCULOSIS PATIENTSAT A HOSPITAL IN BANDUNG, INDONESIA
International Journal of Pharmacy and Pharmaceutical Sciences, 2015
[20] Tuberculosis treatment outcomes in patients with resistant tuberculosis at a district hospital in Kwazulu-Natal Province of South Africa
Pula: Botswana Journal of African Studies, 2015
[21] Human Leukocyte Antigen-G (HLA-G) 14-bp deletion polymorphism is associated with decreased risk of pulmonary fibrosis in Indonesian Javanese patients …
2015